Gene therapy approaches for Parkinson’s disease aim to modify or supplement gene expression to restore dopamine signaling, protect neurons, or modulate disease pathways. Recent advances show improved vector delivery, better safety profiles, and early signals of clinical benefit, though challenges remain around long-term efficacy, targeting, and scalability. Alzheimer’s & Neurodegeneration Education Series
